Elan Corporation said this morning that it had received $89.5m in cash from its investment in Xcel Pharmaceuticals.
The Athlone-based company said the proceeds from the transaction will go towards its recovery plan. To date, the total cash received by Elan though asset divestitures is over $825m.
